Transferrin Receptor-Mediated Endocytosis: A Useful Target for Cancer Therapy

Grants

Funding Acknowledgements

The support of the Australian Institute of Nuclear Science and Engineering (AINSE) is acknowledged. TCK was the recipient of AINSE awards. TCK is supported by an Australian Research Council Future Fellowship and the Epigenomic Medicine Laboratory is supported by McCord Research. Supported in part by the Victorian Government's Operational Infrastructure Support Program.